Laminate Medical

What Laminate Medical does

Laminate Medical Technologies Ltd. is an Israel-based, privately held medical device company founded in 2012 and headquartered in Tel Aviv. The company develops and commercializes the VasQ™ extravascular support device, a nitinol implant designed to improve arteriovenous fistula (AVF) maturation outcomes in hemodialysis patients. VasQ is implanted externally around the vein and artery connection during AV fistula creation surgery, providing permanent structural reinforcement at the anastomosis to reduce turbulent flow, wall tension, and intimal hyperplasia — the root causes of fistula maturation failure, which affects 25-50% of fistulas globally. The device is offered in sizes 4B, 5B, 6B, and 7B based on vessel diameter and can be implanted in approximately one minute without contacting blood circulation or requiring suturing to blood vessels.

VasQ is the first and only FDA-cleared extravascular support device for AVF creation, having received FDA Breakthrough Device Designation in June 2020 and FDA De Novo approval in September 2023. Reimbursement is supported in the US by CMS Transitional Pass-Through Payment under HCPCS code C8000 (effective October 2024 through September 2027), in Germany by NUB Status 1 designation across 321 hospitals (since 2017), and in the UK through an NHS Supply Chain partnership. Clinical evidence supporting the device includes a 144-patient US pivotal study across 17 sites, an 80-patient EU VALUE post-market study, a propensity-score matched Medicare analysis, and the Shahverdyan real-world series of 150 forearm fistula patients demonstrating 84% secondary patency at 36 months and 90% of fistulas used for dialysis within a median 41 days.

Laminate operates a clinical-evidence-based go-to-market model targeting vascular surgeons and nephrologists through direct hospital sales in the US and a network of regional distributors across Europe (UK, Italy, Austria, Greece, Sweden, Germany, France, Spain), Africa, and Singapore. The company maintains offices in Tel Aviv (headquarters), Berlin (European operations), and New York (US commercial operations), and is led by CEO and co-founder Tammy Gilon. The company has raised approximately $20 million in disclosed funding across rounds in 2015, 2017, and 2019 from investors including Asahi Kasei, Tal Capital, and Valiance Asset Management.

Name

Laminate Medical

Legal name

Laminate Medical Technologies Ltd.

Website

https://laminatemedical.com

Company type

Private

Founded year

2012

Operating status

Operating

Headcount range

11–50 employees

Short description

Laminate Medical Technologies is an Israel-based medical device company that develops and commercializes the VasQ extravascular nitinol support device to improve arteriovenous fistula maturation outcomes for hemodialysis patients globally.

Ownership category

akta.pro rank

Product category

Vascular Access Medical Devices

NAICS

Surgical Appliance and Supplies Manufacturing (339113), Surgical and Medical Instrument Manufacturing (339112)

SIC

Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Vascular Access Devices (AV Grafts, Catheters, Fistula Accessories) (HLAHAKAE)

Keywords

• Vascular access devices
• Hemodialysis medical devices
• Arteriovenous fistula support
• Nitinol implantable devices
• Vascular surgery equipment

Headquarters

HQ city

Tel Aviv

HQ country

Israel

HQ region

Middle East

Offices3 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Operations, Supply Chain, Technology or R&D, Personnel, Marketing or Sales, Infrastructure

Revenue model

1. Medical Device Sales - VasQ: Sale of VasQ extravascular support devices to hospitals and healthcare providers for use in arteriovenous fistula creation surgeries. Revenue is generated through direct hospital purchases and distributor sales. Reimbursement supported by CMS TPT payment (code C8000) in the US and NUB Status 1 in Germany.

Pricing tiers

Go-to-market motion1 record

Distribution channels2 records

Marketing channels6 records

Core offering

Laminate Medical Technologies Ltd. designs, manufactures, and commercializes the VasQ extravascular support device, an implantable nitinol scaffold implanted around the vein-artery connection during arteriovenous fistula (AVF) creation surgery for hemodialysis patients. The device provides permanent structural reinforcement at the anastomosis, regulating blood flow geometry and reinforcing the perianastomotic vein against wall tension and turbulent flow to improve fistula maturation. The company sells VasQ in the US, EU, UK, Africa, and Asia Pacific through direct hospital sales and regional distributors.

Product overview

Laminate Medical is a single-product medical device company focused on advancing arteriovenous fistula (AVF) function for hemodialysis patients. The company's sole product is the VasQ™ extravascular support device, which is implanted around the vein and artery connection during fistula creation to provide structural support and guide fistula maturation. The device addresses the root causes of AVF failure by regulating flow through constraining optimal geometrical parameters and reinforcing the perianastomotic vein against high pressure, wall tension, and flow levels. The company operates globally with distribution in the United States, Europe, UK, Africa, and Asia Pacific.

Differentiator

Problem solved

Functional benefit

Products and services

• VasQ Extravascular Support Device Implantable nitinol extravascular support device implanted around the vein and artery connection during arteriovenous fistula creation surgery to provide permanent structural reinforcement at the anastomosis, regulate blood flow geometry, and reduce wall tension and turbulent flow to improve fistula maturation for hemodialysis patients. Available in sizes 4B, 5B, 6B, and 7B based on vessel diameter. Implantation takes approximately 1 minute, does not contact blood circulation, and requires no suturing to blood vessels. Indicated for brachiocephalic and radiocephalic AVF procedures.

Quantifiable outcome

• 76.9% unassisted maturation rate in proximal ulnar AVFs supported by VasQ
• +5 more outcomes

Named customers4 records

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Partnerships

Six partnerships are on record, tiered core, support and regional.

• KimalcoreChannel Partner/ Reseller/ Distributor · 21 April 2025Official VasQ UK partner. Joint presence at CX International Symposium and VASBI Annual Scientific Meeting. Kimal provides distribution and market access support in the UK.
• PRIA HealthcaresupportImplementation/ SI/ Consulting Partner · 1 October 2024Reimbursement support partner for US market. Contact for VasQ coding, coverage, and payment information. Handles TPT payment inquiries and hospital cost-to-charge ratio guidance.
• NHS Supply ChaincoreStrategic or Co-development Partner · 25 June 2023NHS Innovation Services partnered with Laminate Medical in a novel approach to allow NHS to evaluate the potential of VasQ to reduce UK healthcare costs while improving patient lives. The NHS reported the device will be fully introduced to market with support from NHS Supply Chain.
• Myton MedtechregionalChannel Partner/ Reseller/ DistributorUK distributor for VasQ product distribution.
• TOPMED PTE LTDregionalChannel Partner/ Reseller/ DistributorSingapore distributor for VasQ in Asia Pacific region.
• Kingfisher Medical SuppliesregionalChannel Partner/ Reseller/ DistributorAfrica distributor for VasQ product distribution.

Scale indicators6 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• Teleflex: Teleflex provides vascular access devices including dialysis catheters and surgical instruments; it competes for the same hospital vascular access procedure budgets as Laminate Medical across US and EMEA.
• Medtronic: Medtronic's Vascular Therapies and Renal Denervation portfolios include venous and arterial access devices; as a broad incumbent Medtronic competes for hospital vascular surgery budgets and shares payer relationships with Laminate Medical.
• Getinge (Maquet Vascular): Getinge's Vascular Solutions business sells vascular grafts, patches, and closure devices used in open vascular and dialysis access surgery, overlapping Laminate's procedural setting and customer base.
• Becton Dickinson (BD): BD (including the legacy Bard business) is a major player in vascular access including dialysis catheters and AVF products, serving the same hospitals and vascular surgeons with a broader portfolio that overlaps Laminate's target accounts and channels.

Emerging players

• InnAVasc Medical: InnAVasc is developing a subcutaneous vascular access device designed to improve AV fistula creation for hemodialysis, making it an emerging peer pursuing the same clinical problem with an alternative extravascular approach.
• CorMedix: CorMedix develops and markets products targeting vascular catheter-related bloodstream infections in hemodialysis patients (e.g., DefenCath), addressing the same dialysis patient population and vascular access use case with partial category overlap.
• Artio Medical: Artio Medical is an early-stage developer of endovascular and vascular access devices for AV fistula and dialysis access procedures, representing an emerging peer in the same nascent niche served by Laminate.
• Avenu Medical (acquired by BD): Avenu Medical developed the everlinQ endoAVF system for percutaneous AV fistula creation as an alternative approach to surgical AVF; though now part of BD, it represents an emerging approach targeting the same hemodialysis vascular access indication.

Direct peers

• W. L. Gore & Associates: Gore manufactures prosthetic vascular grafts (e.g., GORE-TEX vascular grafts) used in arteriovenous access and bypass procedures, making it the closest direct comparable as an implantable device manufacturer serving AV access surgery in vascular surgery settings.
• Cook Medical: Cook Medical has a dedicated Vascular division that sells dialysis catheters and AV access products directly to vascular surgeons and hospitals, making it a direct peer in the AVF procedural armamentarium.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/laminate-medical-technologies-ltd-

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Subsidiaries2 records

Funding overview

Funding rounds5 records

Investors8 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Laminate Medical